Topic:

Chutes and Ladders

Latest Headlines

Latest Headlines

GlaxoSmithKline weighs RBS chair to replace board chief Gent

The parade of new pharma board chairs is growing longer. GlaxoSmithKline is reportedly eyeing Sir Philip Hampton, now chairman at Royal Bank of Scotland, to take up where Sir Christopher Gent leaves off next year, according to the London Evening Standard.

Roche lands Lufthansa CEO to take over chairman's job

When Novartis needed a new chairman this year, it chose a pharma executive for the job. Roche, its crosstown rival, is flying in a different direction. The Swiss drugmaker picked Lufthansa CEO Christoph Franz to take Franz Humer's seat at the head of its boardroom table.

Ex-Bausch + Lomb CEO takes helm at Forest Labs

Welcome to this week's roundup of hirings and firings throughout the industry. Please send the good word (or the bad) from your shop to Michael Gibney (email | Twitter) or Emily Mullin (email |...

Cold Spring Harbor Lab names Teri Willey as new BD chief

Teri Willey has stepped in to take over as vice president of business development and technology transfer at Cold Spring Harbor Laboratory.

Forest Labs taps ex-Bausch + Lomb chief to replace Solomon as CEO

Forest Laboratories has snapped up former Bausch + Lomb CEO Brent Saunders to replace Howard Solomon, who is retiring. Shunted aside when Valeant Pharmaceuticals bought B+L, Saunders was something of a natural choice for Forest, because he has served on the company's board since 2011. He'll step into his new role Oct. 1.

Boehringer targets sales reps in new round of French job cuts

Boehringer Ingelheim has been on a job-cutting spree in recent months. The German drugmaker has shuttered plants in France and the U.S. and cut jobs at other manufacturing facilities. Now, the company is applying its scalpel to sales and administration in France.

My next mission: Sharing discoveries from Novartis

I'm tackling a new career challenge. Next month I plan to join Novartis Institutes for BioMedical Research (NIBR) in Cambridge, MA, to manage social media. It means that two weeks from today I will end a thrilling experience as executive editor of the life sciences group at FierceMarkets.

Vivus CEO steps down citing health reasons

Welcome to this week's roundup of hirings and firings throughout the industry. Please send the good word (or the bad) from your shop to Michael Gibney (email | Twitter) or Emily Mullin (email |...

Vivus CEO bows out for health reasons; former J&J exec to step in

Just as the dust was settling at Vivus, its new CEO, Tony Zook, has resigned for health reasons. Zook's sudden exit, effective today, follows his almost-as-sudden entrance as CEO in July after a bitter proxy war put rebel investors in charge.

Takeda fills newly created CFO position

Welcome to this week's roundup of hirings and firings throughout the industry. Please send the good word (or the bad) from your shop to Michael Gibney (email | Twitter) or Emily Mullin (email |...